PharmacologyChurchill Livingstone, 2001 - 839 pagine Adapted for the U.S., this New Edition of PHARMACOLOGY, a popular UK text, describes what drugs do and emphasizes the mechanisms by which they act. The U.S. edition is revised and updated to reflect the substantial differences in drug names, FDA approvals, terminology, and guidelines for use. It also boasts new and revised chapters to ensure that students are up to date on the very latest information. Each chapter begins with a summary of information essential to the chapter and key points are highlighted within the text to alert students to crucial concepts. Spanish version also available, ISBN: 84-8174-492-1 |
Dall'interno del libro
Risultati 1-3 di 77
Pagina 53
... treatment ( A ) with that of a control group receiving an existing “ standard ” treatment ( B ) . Treatment A might be a new drug or a new combination of existing drugs , or any other kind of therapeutic intervention such as a surgical ...
... treatment ( A ) with that of a control group receiving an existing “ standard ” treatment ( B ) . Treatment A might be a new drug or a new combination of existing drugs , or any other kind of therapeutic intervention such as a surgical ...
Pagina 279
... treatment of hypertension and shock ⚫ the resistance of individual vascular beds , which determines the local distribution of blood flow to and within different organs ; such effects are relevant to the drug treatment of angina ( Ch ...
... treatment of hypertension and shock ⚫ the resistance of individual vascular beds , which determines the local distribution of blood flow to and within different organs ; such effects are relevant to the drug treatment of angina ( Ch ...
Pagina 510
... treatment for PD and is nearly always combined with a peripheral dopa decarboxylase inhibitor , either carbidopa or benserazide , which reduces the dose needed by about 10 - fold and diminishes the peripheral side - effects . It is well ...
... treatment for PD and is nearly always combined with a peripheral dopa decarboxylase inhibitor , either carbidopa or benserazide , which reduces the dose needed by about 10 - fold and diminishes the peripheral side - effects . It is well ...
Sommario
general principles | 11 |
molecular aspects | 19 |
Method and measurement in pharmacology | 47 |
Copyright | |
45 sezioni non visualizzate
Altre edizioni - Visualizza tutto
Parole e frasi comuni
5-HT receptors absorption acetylcholine action potential activity adrenoceptors agents agonists amino acids anesthetics antidepressant antipsychotic asthma benzodiazepines binding block blood bradykinin brain Ca2+ cancer cardiac cause cells chemical cholinergic clinical compounds cytokines decrease depolarization depression disease diuretics dopamine dose drugs enzyme estrogens ethanol excretion factors function GABA gastrointestinal gene glucocorticoids glucose glutamate histamine hormone important inactivation increase inflammatory inhibition inhibitors injection insulin interaction intracellular intravenous kinase leptin liver mainly mechanism of action mediators membrane metabolism metabolites molecular molecules morphine muscarinic nerve terminals neurons nicotine norepinephrine normal occurs opioid orally oxide pathway patients peptide peripheral Pharmacokinetic Pharmacol pharmacological physiological pituitary plasma concentration platelet presynaptic produce prostaglandins protein reactions receptor antagonists reduced release renal response result role secretion side-effects smooth muscle sodium stimulation substance sympathetic synaptic synthesis therapeutic therapy tissue toxicity transmission transmitter treatment tubule unwanted effects uptake vascular vasoconstriction vitamin